Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data
Crossref DOI link: https://doi.org/10.1007/s00280-016-2994-x
Published Online: 2016-03-03
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wendling, Thierry
Mistry, Hitesh
Ogungbenro, Kayode
Aarons, Leon
License valid from 2016-03-03